Citigroup Global Markets Holdings Inc. is issuing auto-callable securities linked to CVS Health Corporation, due December 23, 2027. The securities offer quarterly contingent coupon payments at 12.25% per annum if CVS stock closes at or above the 70% coupon threshold. They feature potential early redemption and full downside exposure.The securities will be automatically redeemed if CVS stock closes at or above the initial level on any quarterly observation date from March 2025. If not called early, investors risk losing principal if CVS stock closes below the 70% barrier at maturity. The estimated initial value is $912.40 per $1,000 security, below the issue price.Wells Fargo Securities is the selling agent, receiving a 2.325% fee. The securities are subject to the credit risk of Citigroup. Investors should carefully consider the risks, including potential loss of principal, before investing.

Citigroup Global Markets Holdings Inc. is issuing auto-callable securities linked to CVS Health Corporation, due December 23, 2027. The securities offer quarterly contingent coupon payments at 12.25% per annum if CVS stock closes at or above the 70% coupon threshold. They feature potential early redemption and full downside exposure.The securities will be automatically redeemed if CVS stock closes at or above the initial level on any quarterly observation date from March 2025. If not called early, investors risk losing principal if CVS stock closes below the 70% barrier at maturity. The estimated initial value is $912.40 per $1,000 security, below the issue price.Wells Fargo Securities is the selling agent, receiving a 2.325% fee. The securities are subject to the credit risk of Citigroup. Investors should carefully consider the risks, including potential loss of principal, before investing.